Original Research Article
An MRI-Based Semiquantitative Index for the Evaluation of Brain Atrophy and Lesions in Alzheimer’s Disease, Mild Cognitive Impairment and Normal AgingChen W.a, g · Song X.a, b · Zhang Y.g · Darvesh S.c, e · Zhang N.a, g · D’Arcy R.C.N.a, d · Black S.f · Rockwood K.b, e
aNational Research Council Canada, Institute for Biodiagnostics (Atlantic), bDivision of Geriatric Medicine, Department of Medicine, cDepartments of Medicine (Neurology) and Anatomy and Neurobiology, and dDepartments of Radiology and Psychology and Neuroscience, Dalhousie University, and eCentre for Health Care of the Elderly, QEII Health Sciences Centre, Halifax, N.S., and fDepartment of Medicine (Neurology) and Heart and Stroke Foundation Centre for Stroke Recovery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont., Canada; gDepartment of Radiology of the General Hospital, Tianjin Medical University, Tianjin, China
Xiaowei Song, PhD, MSCS; Kenneth Rockwood, MD, FRCPC
Neuroimaging Research Laboratory, National Research Council Canada
Institute for Biodiagnostics (Atlantic)
Suite 3900, 1796 Summer Street, Halifax, NS B3H 3A7 (Canada)
E-Mail Xiaowei.Song@nrc.ca; Kenneth.Rockwood@dal.ca
Do you have an account?
Background: This study investigates how T1-weighted MRI can be used to evaluate brain anatomical changes. We investigated these changes in Alzheimer’s disease (AD) and normal aging. Methods: A semiquantitative brain atrophy and lesion index (BALI) was constructed by adapting existing visual rating scales and validated in 3 datasets. Results: The T1- and T2-weighted-imaging-based scores were highly correlated. They were both closely associated with age and with cognitive test scores. Conclusion: The T1-based BALI helps describe brain structural variability in AD, mild cognitive impairment and normal aging.
© 2010 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.